As of December 2024, Synmosa Biopharma Corporation has a market cap of $396.64M. This makes Synmosa Biopharma Corporation the world's 12607th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $455.49M | 0.13% |
2023 | $454.90M | -20.64% |
2022 | $573.19M | 106.36% |
2021 | $277.77M | 3.74% |
2020 | $267.76M | 12.66% |
2019 | $237.66M | -1.61% |
2018 | $241.55M | 16.59% |
2017 | $207.17M | -3.81% |
2016 | $215.39M | -8.37% |
2015 | $235.06M | -4.58% |
2014 | $246.35M | 14.42% |
2013 | $215.30M | 4.99% |
2012 | $205.07M | 60.06% |
2011 | $128.12M | -22.07% |
2010 | $164.41M | -7.60% |
2009 | $177.94M | 84.56% |
2008 | $96.41M | -27.89% |
2007 | $133.70M | - |